SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-345937
Filing Date
2021-12-02
Accepted
2021-12-02 07:01:00
Documents
14
Period of Report
2021-12-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d267338d8k.htm   iXBRL 8-K 25736
2 EX-99.1 d267338dex991.htm EX-99.1 161604
6 GRAPHIC g267338dsp1.jpg GRAPHIC 2583
  Complete submission text file 0001193125-21-345937.txt   334059

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20211202.xsd EX-101.SCH 2885
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20211202_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20211202_pre.xml EX-101.PRE 11403
7 EXTRACTED XBRL INSTANCE DOCUMENT d267338d8k_htm.xml XML 3385
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 211464928
SIC: 2834 Pharmaceutical Preparations